379 related articles for article (PubMed ID: 26732588)
21. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
[TBL] [Abstract][Full Text] [Related]
22. Exploring the relationship between Endothelin-1 and peripheral inflammation in multiple sclerosis.
Rocha NP; Colpo GD; Bravo-Alegria J; Lincoln JA; Wolinsky JS; Lindsey JW; Teixeira AL; Freeman L
J Neuroimmunol; 2019 Jan; 326():45-48. PubMed ID: 30472305
[TBL] [Abstract][Full Text] [Related]
23. Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis.
Trenova AG; Slavov GS; Manova MG; Kostadinova II
Arch Med Res; 2014 Aug; 45(6):495-500. PubMed ID: 25130430
[TBL] [Abstract][Full Text] [Related]
24. The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones.
Roomruangwong C; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Sirivichayakul S; Carvalho A; Barbosa DS; Maes M
J Psychosom Res; 2020 Aug; 135():110158. PubMed ID: 32526539
[TBL] [Abstract][Full Text] [Related]
25. Plasma lipid peroxidation and progression of disability in multiple sclerosis.
Koch M; Mostert J; Arutjunyan AV; Stepanov M; Teelken A; Heersema D; De Keyser J
Eur J Neurol; 2007 May; 14(5):529-33. PubMed ID: 17437612
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Costa NT; Scavuzzi BM; Iriyoda TMV; Lozovoy MAB; Alfieri DF; de Medeiros FA; de Sá MC; Micheletti PL; Sekiguchi BA; Reiche EMV; Maes M; Simão ANC; Dichi I
Clin Exp Med; 2018 Aug; 18(3):363-372. PubMed ID: 29644482
[TBL] [Abstract][Full Text] [Related]
27. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
28. Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patients.
Kartau M; Kartau J; Pohja M; Verkkoniemi-Ahola A
Brain Behav; 2024 Jan; 14(1):e3377. PubMed ID: 38376020
[TBL] [Abstract][Full Text] [Related]
29. Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis.
Trenova AG; Slavov GS; Manova MG; Draganaova-Filipova MN; Mateva NG; Miteva LD; Stanilova SA
Scand J Clin Lab Invest; 2017 Jul; 77(4):283-288. PubMed ID: 28319417
[TBL] [Abstract][Full Text] [Related]
30. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
31. Increased serum levels of some inflammatory markers in patients with multiple sclerosis.
Uysal S; Meriç Yilmaz F; Boğdaycioğlu N; Mungan Öztürk S; Ak F
Minerva Med; 2014 Jun; 105(3):229-35. PubMed ID: 24988088
[TBL] [Abstract][Full Text] [Related]
32. Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients.
El-Salem K; Al-Mistarehi AH; Hanan Khalil ; Alham Al-Sharman ; Yassin A
Mult Scler Relat Disord; 2021 Jan; 47():102621. PubMed ID: 33197871
[TBL] [Abstract][Full Text] [Related]
33. Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.
Oliveira SR; Flauzino T; Sabino BS; Kallaur AP; Alfieri DF; Kaimen-Maciel DR; Morimoto HK; de Almeida ERD; Lozovoy MAB; Reiche EMV; Dichi I; Simão ANC
Metab Brain Dis; 2018 Oct; 33(5):1393-1399. PubMed ID: 29797117
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts.
Vargas HO; Nunes SO; Pizzo de Castro M; Bortolasci CC; Sabbatini Barbosa D; Kaminami Morimoto H; Venugopal K; Dodd S; Maes M; Berk M
J Affect Disord; 2013 Sep; 150(3):923-30. PubMed ID: 23856278
[TBL] [Abstract][Full Text] [Related]
35. Reduction of nitric oxide and DNA/RNA oxidation products are associated with active disease in systemic lupus erythematosus patients.
Iriyoda TMV; Stadtlober N; Lozovoy MAB; Delongui F; Costa NT; Reiche EMV; Dichi I; Simão ANC
Lupus; 2017 Sep; 26(10):1106-1111. PubMed ID: 28420072
[TBL] [Abstract][Full Text] [Related]
36. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
Ludwig MD; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
[TBL] [Abstract][Full Text] [Related]
37. Immune-Inflammatory, Metabolic, Oxidative, and Nitrosative Stress Biomarkers Predict Acute Ischemic Stroke and Short-Term Outcome.
Alfieri DF; Lehmann MF; Flauzino T; de Araújo MCM; Pivoto N; Tirolla RM; Simão ANC; Maes M; Reiche EMV
Neurotox Res; 2020 Aug; 38(2):330-343. PubMed ID: 32415527
[TBL] [Abstract][Full Text] [Related]
38. The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients.
Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; de Oliveira KB; Simão ANC; Reiche EMV
Inflamm Res; 2019 Nov; 68(11):933-943. PubMed ID: 31414141
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke.
de Sousa Parreira J; Kallaur AP; Lehmann MF; Oliveira SR; Alfieri DF; Delongui F; de Araújo MC; Rossato C; de Almeida JT; Pelegrino LM; Bragato EF; Morimoto HK; Simão AN; Kaimen-Maciel DR; Reiche EM
Metab Brain Dis; 2015 Feb; 30(1):159-67. PubMed ID: 25063351
[TBL] [Abstract][Full Text] [Related]
40. Serum NSE level and disability progression in multiple sclerosis.
Koch MW; George S; Wall W; Wee Yong V; Metz LM
J Neurol Sci; 2015 Mar; 350(1-2):46-50. PubMed ID: 25686504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
